These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 403561)

  • 21. Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Sep; 67(1):115-22. PubMed ID: 574039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMT catalepsy and hypokinesia: interaction with morphine and cocaine.
    Papeschi R; Theiss P; Ayhan H
    Psychopharmacologia; 1976 Mar; 46(2):149-57. PubMed ID: 986053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenergic influences on catalepsy.
    Mason ST; Roberts DC; Fibiger HC
    Psychopharmacology (Berl); 1978 Dec; 60(1):53-7. PubMed ID: 104346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible mechanisms of sustained tremor induction by nicotine in pilocarpine treated animals.
    Dohi T; Tsujimoto A
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):62-72. PubMed ID: 153736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Oct; 67(2):309-18. PubMed ID: 40649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists.
    Consolo S; Forloni G; Ladinsky H; Palazzi E
    Brain Res; 1988 May; 449(1-2):97-103. PubMed ID: 2899450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities of the cataleptic state induced by beta-endorphin and morphine.
    Rondeau DB; Turcotte M; Young L; Hebert D
    Pharmacol Biochem Behav; 1982 Oct; 17(4):703-7. PubMed ID: 6294679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On a prime role for newly synthesized dopamine in striatal function.
    Shore PA; Dorris RL
    Eur J Pharmacol; 1975 Feb; 30(2):315-8. PubMed ID: 1168577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of benzodiazepines with neuroleptics at central dopamine neurons.
    Keller HH; Schaffner R; Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):1-7. PubMed ID: 12477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.
    Sharman DF
    Br J Pharmacol Chemother; 1966 Nov; 28(2):153-63. PubMed ID: 5972623
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083
    [No Abstract]   [Full Text] [Related]  

  • 32. Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs.
    Zetler G
    Int J Neuropharmacol; 1968 Jul; 7(4):325-35. PubMed ID: 5752933
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
    Onodera K; Shinoda H
    Agents Actions; 1991 May; 33(1-2):143-6. PubMed ID: 1897431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cholinergic system and nociception in the primate: interactions with morphine.
    Pert A
    Psychopharmacologia; 1975 Oct; 44(2):131-7. PubMed ID: 708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic.
    Majocha R; Baldessarini RJ
    Life Sci; 1984 Nov; 35(22):2247-55. PubMed ID: 6503612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic-dopaminergic interactions in experimental catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1983; 81(1):24-7. PubMed ID: 6415727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.